ATE239467T1 - Methode zur behandlung oder verhütung von interstitieller blasenentzundung - Google Patents

Methode zur behandlung oder verhütung von interstitieller blasenentzundung

Info

Publication number
ATE239467T1
ATE239467T1 AT97914868T AT97914868T ATE239467T1 AT E239467 T1 ATE239467 T1 AT E239467T1 AT 97914868 T AT97914868 T AT 97914868T AT 97914868 T AT97914868 T AT 97914868T AT E239467 T1 ATE239467 T1 AT E239467T1
Authority
AT
Austria
Prior art keywords
blidder
inflammation
treating
preventing interstitial
interstitial
Prior art date
Application number
AT97914868T
Other languages
English (en)
Inventor
Smriti Iyengar
Mark A Muhlhauser
Karl B Thor
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE239467T1 publication Critical patent/ATE239467T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Threshing Machine Elements (AREA)
  • Processing Of Meat And Fish (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nozzles (AREA)
  • Pistons, Piston Rings, And Cylinders (AREA)
  • Transplanting Machines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heat Treatment Of Articles (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97914868T 1996-03-11 1997-03-07 Methode zur behandlung oder verhütung von interstitieller blasenentzundung ATE239467T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1315796P 1996-03-11 1996-03-11
PCT/US1997/003410 WO1997033880A1 (en) 1996-03-11 1997-03-07 Methods of treating or preventing interstitial cystitis

Publications (1)

Publication Number Publication Date
ATE239467T1 true ATE239467T1 (de) 2003-05-15

Family

ID=21758595

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97914868T ATE239467T1 (de) 1996-03-11 1997-03-07 Methode zur behandlung oder verhütung von interstitieller blasenentzundung

Country Status (23)

Country Link
EP (1) EP0888330B1 (de)
JP (1) JP2000506863A (de)
KR (1) KR19990087671A (de)
CN (1) CN1217721A (de)
AT (1) ATE239467T1 (de)
AU (1) AU730448B2 (de)
BR (1) BR9708027A (de)
CA (1) CA2250288A1 (de)
CZ (1) CZ287798A3 (de)
DE (1) DE69721747T2 (de)
DK (1) DK0888330T3 (de)
EA (1) EA001325B1 (de)
ES (1) ES2197993T3 (de)
HU (1) HUP9902884A3 (de)
IL (1) IL126159A (de)
NO (1) NO984160D0 (de)
NZ (1) NZ331811A (de)
PL (1) PL328959A1 (de)
PT (1) PT888330E (de)
RO (1) RO117296B1 (de)
UA (1) UA62926C2 (de)
WO (1) WO1997033880A1 (de)
YU (1) YU39598A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69941712D1 (de) 1998-09-15 2010-01-07 Lilly Co Eli Verwendung von duloxetine zur behandlung von fibromyalgie
WO2002078691A1 (en) * 2001-03-29 2002-10-10 Eli Lilly And Company Duloxetine for treatment of hot flashes
EP1485078B1 (de) * 2002-03-15 2012-09-26 Cypress Bioscience, Inc. Milnacipran zur Behandlung von Reizdarmsyndrom
DE10247689A1 (de) * 2002-10-12 2004-04-22 Martin Rahe Implantat in der Harnblase
EP1424079A1 (de) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Kombination eines beta-3-Rezeptoragonisten und eines Serotonin und/oder Norepinephrin-Wiederaufnahmeinhibitors
JP2008543929A (ja) * 2005-06-20 2008-12-04 カディラ・ヘルスケア・リミテッド デュロキセチンの調節放出型の投与製剤
BRPI0720958A2 (pt) * 2006-12-27 2014-03-18 Lek Pharmaceuticals Omposição de duloxetina
EP1938840A1 (de) * 2006-12-27 2008-07-02 LEK Pharmaceuticals D.D. Duloxetinzusammensetzung
EP2018860A1 (de) * 2007-07-16 2009-01-28 LEK Pharmaceuticals D.D. Duloxetinzusammensetzung
WO2009066181A2 (en) * 2007-07-09 2009-05-28 Combino Pharm, S.L. Oral delayed-release duloxentine hydrochloride pellets
RU2719929C1 (ru) * 2018-12-17 2020-04-23 Юрий Анатольевич Игнашов Способ выбора лечения женщин с синдромом болезненного мочевого пузыря

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US574474A (en) * 1897-01-05 Course-indicating apparatus
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence

Also Published As

Publication number Publication date
EA199800816A1 (ru) 1999-02-25
ES2197993T3 (es) 2004-01-16
HUP9902884A3 (en) 2000-12-28
NZ331811A (en) 2001-04-27
UA62926C2 (en) 2004-01-15
BR9708027A (pt) 1999-08-03
AU730448B2 (en) 2001-03-08
KR19990087671A (ko) 1999-12-27
JP2000506863A (ja) 2000-06-06
IL126159A0 (en) 1999-05-09
EA001325B1 (ru) 2001-02-26
DE69721747T2 (de) 2004-04-01
NO984160L (no) 1998-09-10
WO1997033880A1 (en) 1997-09-18
EP0888330A4 (de) 1999-04-07
HUP9902884A2 (en) 2000-07-28
PL328959A1 (en) 1999-03-01
CZ287798A3 (cs) 1999-05-12
EP0888330B1 (de) 2003-05-07
EP0888330A1 (de) 1999-01-07
RO117296B1 (ro) 2002-01-30
IL126159A (en) 2003-01-12
DE69721747D1 (de) 2003-06-12
CN1217721A (zh) 1999-05-26
CA2250288A1 (en) 1997-09-18
NO984160D0 (no) 1998-09-10
YU39598A (sh) 1999-09-27
PT888330E (pt) 2003-09-30
DK0888330T3 (da) 2003-09-01
AU2196297A (en) 1997-10-01

Similar Documents

Publication Publication Date Title
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
ATE411016T1 (de) Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten
ATE207356T1 (de) Verwendung von tiagabin zur behandlung von schlafstörungen
ATE411018T1 (de) Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en)
ATE239467T1 (de) Methode zur behandlung oder verhütung von interstitieller blasenentzundung
DE69027220D1 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
ATE271873T1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE69924979D1 (de) Behandlung von chronischen schmerzen
EE9700350A (et) COMT-inhibiitorite uus kasutamine ja diabeetiliste vaskulaarsete häirete ärahoidmise meetod
ATE369143T1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
DE69919578D1 (de) VERWENDUNG von NIEDERMOLEKULAREM HEPARIN zur Behandlung und/oder Prophylaxe motoneuronaler Krankheiten
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DE69635282D1 (de) Behandlung der exzessiven aggressivität mit olanzapine
ATE268170T1 (de) Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz
ATE291434T1 (de) Verwendung von angiotensin zur behandlung von krebsmetastasierung
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
BR9708037A (pt) Método para o tratamento de abuso de substância
EA199800818A1 (ru) Способ лечения бессонницы

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0888330

Country of ref document: EP

REN Ceased due to non-payment of the annual fee